Cargando…
Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition
Despite the common usage of radiotherapy for the treatment of NSCLC, outcomes for these cancers when treated with ionizing radiation (IR) are still unsatisfactory. A better understanding of the mechanisms underlying resistance to IR is needed to design approaches to eliminate the radioresistant cell...
Autores principales: | Gomez-Casal, Roberto, Epperly, Michael W., Wang, Hong, Proia, David A., Greenberger, Joel S., Levina, Vera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792558/ https://www.ncbi.nlm.nih.gov/pubmed/26517240 |
Ejemplares similares
-
The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
por: Gomez-Casal, Roberto, et al.
Publicado: (2015) -
Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes
por: Gomez-Casal, Roberto, et al.
Publicado: (2013) -
Antioxidant Approaches to Management of Ionizing Irradiation Injury
por: Greenberger, Joel, et al.
Publicado: (2015) -
Raman Spectroscopic Study of Radioresistant Oral Cancer Sublines Established by Fractionated Ionizing Radiation
por: Yasser, Mohd, et al.
Publicado: (2014) -
ATM is the primary kinase responsible for phosphorylation of Hsp90α after ionizing radiation
por: Elaimy, Ameer L., et al.
Publicado: (2016)